2′,3′-Di-O-acetyl-5′-deoxy-5-fluorocytidine CAS 161599-46-8 Purity ≥99.0% Isithombe Esifakiwe Sefektri Emaphakathi yase-Capecitabine

2′,3′-Di-O-acetyl-5′-deoxy-5-fluorocytidine CAS 161599-46-8 Purity ≥99.0% I-Capecitabine Intermediate Factory

Incazelo emfushane:

Igama: 2′,3′-Di-O-acetyl-5′-deoxy-5-fluorocytidine

I-CAS: 161599-46-8

Ukubukeka: I-Crystalline Powder Emhlophe noma Ephuzi

Isivivinyo: ≥99.0%Ubumsulwa: ≥99.0% (HPLC)

I-Intermediate of Capecitabine (CAS: 154361-50-9)

Ikhwalithi Ephezulu, Ukukhiqizwa Kwezohwebo

Inquiry: alvin@ruifuchem.com

Thumela i-imeyili kithi

Imininingwane Yomkhiqizo

Imikhiqizo Ehlobene

Omaka bomkhiqizo

Incazelo:

I-Commercial Supply Ehlobene Ne-Capecitabine:
I-5-Fluorocytosine CAS: 2022-85-7
2',3'-Di-O-acetyl-5'-deoxy-5-fluorocytidine CAS: 161599-46-8
1,2,3-Tri-O-acetyl-5-deoxy-β-D-ribofuranose CAS: 62211-93-2
I-Capecitabine CAS: 154361-50-9

Chemical Properties:

Igama	2',3'-Di-O-acetyl-5'-deoxy-5-fluorocytidine
Inombolo ye-CAS	161599-46-8
Inombolo yeCAT	I-RF-PI176
Isimo Sesitoko	Esitokweni, Isikali Sokukhiqiza Sifinyelela Kumathani
I-Molecular Formula	I-C13H16FN3O6
Isisindo samangqamuzana	329.28
Isimo Okufanele Usigweme	Ukushisa Kuyazwela
Ibhrendi	I-Ruifu Chemical

Imininingwane:

Into	Imininingwane
Ukubukeka	I-Crystalline Powder Emhlophe noma Ephuzi
Ukungcola Okukodwa	≤0.50%
Ukungcola Okuphelele	≤1.0%
I-Melting Point	178.0~193.0℃
Ukulahlekelwa Ekumisweni	≤0.50%
Izinsalela ekushiseni	≤0.10%
Umswakama (KF)	≤1.0%
Isivivinyo	≥99.0%
Ukuhlanzeka / Indlela Yokuhlaziya	≥99.0% (HPLC)
Izinga Lokuhlola	I-Enterprise Standard
Ukusetshenziswa	I-Intermediate of Capecitabine (CAS: 154361-50-9)

Iphakheji nesitoreji:

Iphakheji: Ibhodlela, isikhwama se-Aluminium foil, isigubhu seCardboard, 25kg/Drum, noma ngokwezidingo zekhasimende.

Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni, umswakama kanye nezinambuzane.

Izinzuzo:

I-FAQ:

Isicelo:

I-Capecitabine (CAS: 154361-50-9) iwuhlobo olusha lomuthi we-oral fluorinated pyrimidine.I-Capecitabine yasungulwa ngabakwa-Roche Pharmaceuticals, futhi igama layo lezentengiso yi-Xeloda.I-Capecitabine ingashintsha ku-vivo ibe yi-5- FU, isidakamizwa esilwa ne-metabolizim fluorine pyrimidine deoxynucleoside carbamate esiqondise amangqamuzana omdlavuza ukuze avimbele ukuhlukana kwamaseli futhi aphazamise i-RNA kanye nokuhlanganiswa kwamaprotheni.Imiphumela yayo iboshelwe kakhulu ezingeni le-TP enzyme expression in neoplastic tissue kanye ne-DPD enzyme ku-vivo expression.Ifanelekile njengokwelashwa okwengeziwe kweziguli ezinomdlavuza webele oyinhloko noma we-metastatic ezingakaphenduli kuma-antibiotic e-paclitaxel noma i-anthracycline.Njengomuthi we-anticancer, usetshenziswa kakhulu ukwelapha umdlavuza webele osezingeni eliphezulu noma we-metastatic, kanye nokwelapha umdlavuza wamaphaphu ongewona omncane, umdlavuza we-pancreatic, umdlavuza wesinye, umdlavuza wamabele, umdlavuza wekoloni, umdlavuza wesisu, nezinye izimila eziqinile. .